Responsibilities:Design pre-clinical in vivo studies to explore novel hypotheses, screen candidate molecules, and establish proof-of-concept of new modalitiesDevelop in vivo CDX, PDX, and syngeneic models to evaluate anti-tumor activity, PK/PD relationships, relevant biomarkers, and key translational questionsManage associate-level scientistsCollaborate with cross-functional project teamsCritically analyze and present results within a multidisciplinary team environmentCareful adherence to animal protocols and proper documentation of data and methods in electronic laboratory notebookQualifications:PhD with 5-8 years of research experience as a postdoc or in the pharmaceutical/biotech industryDeep knowledge of antibody drug conjugatesExtensive experience working with CDX and PDX xenograft tumor models and/or syngeneic modelsExpertise in cell culture, PCR, ELISA, western blot, and flow cytometryStrong analytical, communication (written and verbal), and organizational skills, including a proficiency with PowerPoint and commonly used data analysis programs, such as Prism and ExcelNovartis Compensation and Benefit Summary: The salary for this position is expected to range between $126,000 and $234,000 per year. The successful candidate will join a dynamic, multi-disciplinary team and play a key role in the development and application of in vivo models for evaluating novel cancer therapies and advancing the early-stage drug discovery pipeline.